Vivesto
0.294 SEK -3.77%1 investor is following this company
Vivesto is a research company. The company specializes in the research and development of drugs for serious diseases in oncology. The technology is based on the company's technical platform where research is based on nanotechnology. Today, operations are conducted mainly in the Nordic countries and North America. The company was founded in 1999 and has its headquarters in Uppsala.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
VIVE
Daily low / high price
0.291 / 0.305
SEK
Market cap
157.92M SEK
Turnover
101.75K SEK
Volume
343K
Latest videos
Financial calendar
General meeting
23.05.2024
Interim report
23.05.2024
Interim report
22.08.2024
Interim report
21.11.2024
Annual report
20.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Per Arwidsson med bolag | 24.8 % | 24.8 % |
Avanza Pension | 5.6 % | 5.6 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Vivesto to hold live-streamed Paccal Vet R&D Update on March 26
Vivesto doses first patient in its clinical Paccal Vet trial
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools